Winship Cancer Institute of Emory University — Atlanta, Georgia

Public research footprint of Winship Cancer Institute of Emory University, compiled from the ClinicalTrials.gov public registry.

259

Registered studies

Active

Recruiting now

143

Completed

Stopped or withdrawn

Most-studied conditions

Breast Cancer · Relapsed B-Cell Non-Hodgkin Lymphoma · Multiple Myeloma · Brain Tumor, Adult: Glioblastoma

Recently updated registry entries

NCT07623200 — A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With… (Recruiting)
NCT06065748 — A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a… (Recruiting)
NCT06624085 — A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Winship Cancer Institute of Emory University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.